Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5191_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
68 Мб
Скачать
410
L. Téot et al.
Bruschi S. Surgical debridement with Versajet: an analysis of bacteria load of the wound bed pre- and post-treatment and skin graft taken. A preliminary pilot study. Int Wound J. 2011;8(2):155–61.
5. Sainsbury DC. Evaluation of the quality and cost­effectiveness of Versajet hydrosurgery. Int Wound J. 2009;6(1):24–9. Review.
6. Téot L, Boissiere F, Fluieraru S. Novel foam dress­ing using negative pressure wound therapy with instillation to remove thick exudate. Int Wound J. 2017;14(5):842–8. https://doi.org/10.1111/iwj.12719. Epub 2017 Feb 28.
7. Rohrich RJ. The “soft-tissue wound management: current applications of negative-pressure wound therapy with instillation” supplement. Plast Reconstr Surg. 2021;147(1S-1):1S–2S. https://doi.org/10.1097/
PRS.0000000000007629.
8. Stratmann B, Costea TC, Nolte C, Hiller J, Schmidt J, Reindel J, Masur K, Motz W, Timm J, Kerner W, Tschoepe D.Effect of cold atmospheric plasma ther­apy vs standard therapy placebo on wound healing in patients with diabetic foot ulcers: a randomized clinical trial. JAMA Netw Open. 2020;3(7):e2010411. https://
doi.org/10.1001/jamanetworkopen.2020.10411.
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial­NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by- nc- nd/4.0/), which permits any non­commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if you modied the licensed material. You do not have permission under this license to share adapted material derived from this chapter or parts of it.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Part VIII
Skin Necrosis in Children
Introduction toSkin Necrosis Treatment inYoung Age
LucTéot
64
Skin in young age differs from adults, due to the physiological evolution from the immature skin present in the neonate to a highly inammatory reactive skin, varying during the different stages of the child growth.
Neonatal skin acclimates rapidly to dry, aero­bic conditions at birth, and skin function gradu­ally matures throughout infancy. Three mechanisms are different from adults: oxygen tension-regulating angiogenesis and revascular­ization; transforming growth factor-β (TGF-β) kinetics controlling collagen deposition; and mechanical stretch stimulating cellular mitosis and extracellular matrix remodeling.
There is an increased systemic absorption of topics due to the skin fragility, and the tolerance of adhesives is limited in neonates and infants.
Wound types are more acute, like surgical wounds (extravasation and thermal injuries; chemical burns; pressure ulcers, iatrogenic intra­vascular injections) [1, 2] and wounds secondary to congenital conditions. Wound infection can lead to skin necrosis in highly contaminated situ­ation like bite wounds which require special attention.
Radiations at high doses as well as drug injec­tions may lead to severe skin lesions, including necrosis of the involved area [3, 4].
L. Téot (*) Department of Plastic Surgery, Burns and Wound Healing, Montpellier University Hospital, Hôpital La Colombière, CICAT Occitanie, Montpellier, France e-mail: l-teot@chu-montpellier.fr
Deep wounds with suspected damage to nerves, tendons, and bones need general anes­thetic to explore and assess the lesions. For instance, children and neonates very often receive intravenous therapy. There is a lack of systematic data on the incidence of extravasation injuries in children and neonates. Individual studies involv­ing neonates receiving intravenous therapy on intensive care units report incidence rates of 18–46%. Serious complications, such as necrosis and ulceration, develop in 2.4–4% of cases, which in the long term can lead to contractures, deformities, and loss of limb function secondary to unfavorable scar formation [5]. There are no guidelines available to date on the management of pediatric extravasation injuries.
During childhood, hypertrophic scarring risk is increased, especially in persistent inamma­tory periods like burns, or after surgical recon­struction of necrotic areas using skin grafting or aps and have to be managed properly in propor­tion of the high risk of esthetic and psychological sequelae.

References

1. Koklu E, Ariguloglu AE, Koklu S.Foot Skin Ischemic
Necrosis following Heel Prick in a Newborn.
Case Rep Pediatr. 2013;2013:912876. https://doi.
org/10.1155/2013/912876. Epub 2013 Oct 28.
2. Bakal Ü, Abeş M, Sarac M. Necrosis of the ventral
penile skin ap: a complication of hypospadias surgery
© The Author(s) 2024 L. Téot et al. (eds.), Skin Necrosis, https://doi.org/10.1007/978-3-031-60954-1_64
413
414
L. Té ot
in children. Adv Urol. 2015;2015:452870. https://doi.
org/10.1155/2015/452870. Epub 2015 Apr 1.
3. Ravi M, Ridpath A, Audino AN, Guinipero T, Chung C.Fernandez faith E high-dose methotrexate­induced epidermal necrosis in two pediatric patients. Pediatr Dermatol. 2021;38(3):659–63. https://doi.
org/10.1111/pde.14591. Epub 2021 Apr 7.
4. Brook I.Late side effects of radiation treatment for head and neck cancer. Radiat Oncol J. 2020;38(2):84–92.
https://doi.org/10.3857/roj.2020.00213. Epub 2020
Jun 25.
5. Kostogloudis N, Demiri E, Tsimponis A, Dionyssiou D, Ioannidis S, Chatziioannidis I, Nikolaidis N.Severe extravasation injuries in neonates: a report of 34 cases. Pediatr Dermatol. 2015;32(6):830–5. https://doi.
org/10.1111/pde.12664.
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial­NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by- nc- nd/4.0/), which permits any non­commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if you modied the licensed material. You do not have permission under this license to share adapted material derived from this chapter or parts of it.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
Skin Necrosis inChildren: Physical andInfectious Causes
GuidoCiprandi
65

65.1 Introduction

When we talk about skin necrosis and the under­lying soft tissues, we mean the death of a large number of cells, on the order of billions of cells, with consequent reworking of the tissues that can dehydrate and undergo decay. The nal result is that of a brown, hard eschar, not removable, or a yellow, soft and sometimes soft eschar, with mar­gins indistinguishable from surrounding healthy tissue. In both cases, the visible change on the surface represents only the tip of the iceberg, since the damage is rst warped deeply, in the heart of the soft tissues, until it then reaches the size of a full-thickness damage that subsequently reaches the skin on the surface [1, 2].
In some situations, necrosis occurs secondary to the initial presence of bullous lesions (blister­ing early effect), and the child only after 48–72h begins to manifest an ecchymotic and/or edema­tous skin area that is tinged more and more darkly. As a result, the necrosis proceeds and is much more evidenciating because of the last step of a direct substance-dependent damage or of an indirect damage following an arteriolar-capillary occlusion.
In the pediatric age, necrosis is very fast and whatever the cause that determines the blockage
G. Ciprandi (*) Division of Plastic and Maxillofacial Surgery, Bambino Gesu’ Children’s Hospital, Research Institute, Rome, Italy
of arterial blood ow, locoregional hypo­oxygenation, or secondary damage to lymphatic­venous engorgement, a very rapid outcome in necrosis can be observed [3, 4].
This rapidity is noted for several reasons: on the one hand, the necrosis is due to the insuf­cient number of newly formed capillary beds and to an immaturity of growth and differentiation of the various layers of the skin. In this way, a small insult can already be very serious due to the pov­erty of the capillary networks and therefore cause serious damage with severe tissue loss.
From another perspective, the rapidity of necrosis can be attributed to the physiological edema observed in the neonatal period: the imbi­bition of the lining tissues, much richer in water than in later ages (85–90% in neonatal age and in infants 55–60% in senile ages), reduces the speed with which oxygen diffuses into the skin mantle. Normally, in fact, the oxygen comes out as ultra­ltered from the capillary bed of the dermis until it soaks the tissues of the dermoepidermal layer.
From the pathophysiological point of view, the occlusion pressure of the dermal capillaries, normally equal to 36–38mmHg in adults, is very low in pediatric age and is equal to about 22–24mmHg. Therefore, a much lower pressure is enough to occlude the dermal capillaries and this status is responsible, especially in patients with reduced mobility, for an early damage, often unexpected, with third degree necrotic pressure lesions that appear in less than 24h. All the more reason, the reduction in thickness of the dermo-
© The Author(s) 2024 L. Téot et al. (eds.), Skin Necrosis, https://doi.org/10.1007/978-3-031-60954-1_65
415
416
G. Ciprandi
epidermal complex which is observed from 0 to 36months fails to adequately defend the host’s tissues from the pressures exerted by the hospital materials.
Even the immaturity of the immune system of the youngest patients contributes to the rapid onset of a necrosis of the skin mantle, this time mostly on a septic basis. Poor immaturity is not only systemic in pediatric patients but also locoregional: especially the skin of the extremely preterm infant (LBW—Low Birth Weight, VLBW—Very Low Birth Weight) is structurally and functionally immature at birth [5].
Although there is rapid postnatal maturation, transient hypothermia, and reduced oxygen sup­ply, manifesting ssures and skin breakdowns, with an increase in permeability toward toxins, pathogenic germs, are both responsible for inammation and infection, rst locoregional, and then systemic (Table65.1).
Necrosis is the side effect, sometimes late effect of these crucial events.
Other than vascular occlusive disease, addi­tional pediatric causes of necrosis include intrauter­ine epidermal necrosis, SSFTN, toxic epidermal necrolysis, severe and septic vasculitis (Neisseria meningitidis), drugs and injection extravasation
Table 65.1 Immature skin in different pediatric catego­ries and topical impairment in host defense
Immature skin in different pediatric categories
Premature/preterm Born before 37 wg Late preterm Born between 34 and 36 wg Moderate premature Very premature Born before 32 wg Micropreemie Born at or before 26 wg
A micropreemie is a baby born weighing less than 800g or before 26weeks gestation
Topical impairment in host defense
1. Increased susceptibility to bacterial infections
2. 30% immature neutrophils (vs. 5–15% in childhood)
3. 30% storage pool (vs. 60% in childhood)
4. Severe reduction of myeloid progenitor stem cells
5. Severe impairment in adhesion of GN
6. Severely immature pseudopodal activities and phagocitosis
Born between 32 and 34 wg
(Arginine, Warfarin, Cysplatinum), necrosis result­ing from bang bite and bike accidents or mainly due to inborn error of metabolism. But now let’s go into the specics of some single pathologies capable of inducing skin necrosis in neonatal and pediatric age and let’s focus on these [610].
65.2 SSFTN (Skin andSubcutaneous Fat Necrosis oftheNewborn: “Adiponecrosis Subcutanea Neonatorum”)

65.2.1 General Aspects

This is a rare benign inammatory condition which occurs in strictly neonatal age with rm and tense, well-circumscribed subcutaneous nodules (1–5 cm of largest diameter). Usually, the pre­ferred sites of neonatal brown fat predominance (i.e., cheeks, neck, upper back or sacrococcygeal site, upper arm, thigh, buttocks) are much more affected by these injuries. The skin overlying these nodules looks like red purple induration plaque (sometimes very evident, sometimes quite invisi­ble at the beginning) over the bone prominences, with which subsequently not infrequently under­goes necrosis with extensive ulceration and more often tends to a spontaneous resolution [11, 12].
The age at diagnosis is more often between 4 and 25days, with a peak of incidence between 6 and 12days. In most cases, the gestational age is normal, at term, the newborn weight is age­concordant but a severe perinatal hypoxia it’s almost always part of the medical history: the fetal distress is reported in almost all cases and consequently an emergency cesarean section is required with a primary resuscitation needed, usually during the rst 24–72h of birth. In some cases, the hypoxic-ischemic encephalopathy could intervene [13]. This condition is mainly considered as a form of panniculitis, less severe than sclerema neonatorum, another condition causing hardened skin and limited necrosis dur­ing the neonatal period.
65 Skin Necrosis inChildren: Physical andInfectious Causes
417

65.2.2 Predisposing Factors

There’s neither a prevalent race nor a prevalent gender. However, some maternal predisposing factors have been studied and believed to be ele­ments that may play a role in pathogenesis: pre­eclampsia, gestational type I diabetes, cocaine abuse, and use of calcium channel blockers dur­ing pregnancy have been all investigated and con­sidered as predisposing to SSFTN.
On the other hand, they are believed to be spe­cic neonatal factors in the development of neo­natal adiponecrosis such as hypoxemia, hypothermia, rhesus incompatibility, birth asphyxia, meconium aspiration syndrome, hypo­glycemia, and obstetric trauma (perinatal asphyxia, therapeutic hypothermia). The com­plex and often coincident set of these stressors results in reduced tissue perfusion, and the nal hypoxemia leads to crystallization of free fatty acids in the subcutaneous fat tissue followed by tissue necrosis. Both the ischemia and the drastic inammatory reaction that is activated conse­quently lead to an intense hyperemia and then to necrosis of the overlying skin, with local infec­tion and often stulization or conuence of skin areas of necrosis in the most serious and fortu­nately rare cases.
guided ne-needle aspiration aspirates a thick liponecrotic liquid, otherwise drums of brownish yellow tissue are sent for histopathological exam­ination. The histological pattern is as follows: some nodules are rm; others could become uc­tuant as abscesses. Usually the ne-needle aspi­ration cytology revealed a dirty background with necrotic fat-containing characteristic, radially oriented, refractile, needle-shaped crystals [14,
15]. A tissue pattern-based approach to diagnosis
shows clusters of adipocytes, histiocytes, bro­blasts, scanty lymphocytes, and numerous for­eign body giant cells, granulomatous fat necrosis, and some calcication areas (Fig. 65.1). In a completely different way, sclerema neonatorum (SN) is characterized by hardening of the skin along with edema; histology shows a severe inammatory inltrate and edema in skin as well as in subcutaneous tissues. SN has a high case fatality rate, whereas SSFTN is a self-limiting condition and lesions resolve within a few weeks to months, when a skin necrosis is not part of the clinical pool of signs.

65.2.3 Laboratory Examinations

Serum albumin levels are usually normal, and serum calcium levels may be complicated by increased Ca++ or reduced Ca++ (manifesting with hypotonia and poor suking reex). Whereas, vitamin D levels are normal and PTH is normal or slightly elevated. PLT–platelets showed a marked increase, low Mg and K blood levels.

65.2.4 Diagnosis

The anamnesis allows to highlight a previous fetal distress, associated with impaired calcium blood levels, subcutaneous nodules at various sites (clinical examination), and clearly evident during sonographic examinations: sometimes, if a colliquation has occurred, the ultrasound-
Fig. 65.1 Neonatal adiponecrosis in a 22-day-old patient: areas of skin necrosis overlying a large nodule of subcuta­neous necrosis on the back. Other nodules without subcu­taneous necrosis are present in the neck and right armpit
418
Table 65.2 Team of consultants and aetiopathogenetic steps
Team of consultants
Neonatologist Neurologist Cardiologist Nephrologist Dermatologist Plastic surgeon
Aetiopathogenetic steps
1. Thrombocytosis
2. Lower blood perfusion
3. Hypoxia
4. Hypothermia
5. NSAdiponecrosis (transient panniculitis)
65.2.5 Course andOutcome
Diarrhea and vomiting are the most evident signs associated with the clinical picture, in a sort of self-limited course, with a spontaneous resolu­tion occurring in the following 2 or 3weeks up to 3 months. Specic therapies are not yet estab­lished and if something is required, this is limited to precise complications. In very few cases, low dose prednisone has been administered by mouth.
Among the systemic complication, we must mention hypercalcemia, hypocalcemia, hyperuri­cemia, hypoglycemia, hypertriglyceridemia, thrombocytopenia, resulting in morbidity and mortality, if not early detected and promptly cared.
Local complications are reported such as necrotic epidermal atrophy, ulceration, scarring, and/or local infection. At a discharge breast feed­ing is clearly advocate, and an oral Vit D supple­mentation (1.200UI, each day) is introduced for at least 2–4weeks [5] (Table65.2).
65.3 Extravasation Injuries
Necrosis
65.3.1 Introduction andDenition
Extravasation is the accidental release of one drug or a mixture of them from the veins used for the delivery of solutes and medicaments, into sur­rounding peri and paravascular connective tissue sheats. This phenomenon has an incidence rang­ing from 1 to 6%; however, the severity and type
G. Ciprandi
Fig. 65.2 Yellow necrosis due to extravasation of the saphenous right external to the malleolus in a 12-day-old infant. The necrosis area also affects the subcutaneous tis­sue and is due to extravasation of antibiotics
of treatment vary according to the type of extrav­asated uid [16]. The outcomes of extravasation are related to the characteristics of the patient, his age, the state of the venous circulation, nutri­tional aspects, and various comorbidities. Pediatric patients most at risk are represented by premature (LBW, VLBW, micropreemies) and newborn for the characteristics of the fragile skin and because of a narrow and underdeveloped venous heritage. In rst ages of life, the risk of extravasation and a subsequent necrosis are increased as well as the major late outcomes. The consequences can be of different severity: from local redness to deep tissue necrosis, which can involve tendons and ligaments, causing severe tissue damage and severe functional sequelae and disabilities including contractures, deformities, and loss of function of the limbs secondary to the formation of retracting and/or keloid scars [17,
18] (Figs. 65.2 and 65.3). Some studies con-
ducted in infants admitted to intensive and sub­intensive care units report incidence rates of 18–46%. In 2.4–4% of these cases, serious com­plications develop and necrosis is the most unfa-
65 Skin Necrosis inChildren: Physical andInfectious Causes
419
a
Fig. 65.3 (a, b) Brown eschar affecting the dorsum of the foot due to extravasation of hyperosmolar electrolytic agents after cannulation of the dorsal vein of the left foot.
vorable one, leading to permanent damages if not promptly surgically cared [19].
65.3.2 Actions andInjuries
Based on the potential tissue damage, various agents are recognized and then categorized on the basis of their ability to create the most evident necrotic effects with different mechanisms of action:
1. Transformations from rapid tissue necrosis
are due to substances that produce immediate deep damage and, by binding to DNA, remain in the tissues for a long time causing progres­sive and worsening injuries, with severe necrotic ulcers or full-thickness necrosis which more often appear as real plaque of rigid, black or dark brown tissue, shaped on the anatomical site of the lesion. In these small patients, the plastic surgeon interven­tion is rapidly advocated. Severe pain and functional outcomes are always present if a surgical treatment is not instituted and some­times even in an emergency regime.
2. Blistering substances that can cause deep tis-
sue damage, as they are rapidly metabolized and cause severe or prolonged pain, they rep­resent the second category of agents respon­sible for tissue necrosis, more often circumscribed and limited to small islands of
b
A large surface of about 5cm is involved, as can be seen from the completely removed eschar, which also traces the convexity of the neck and back of the entire foot
skin that undergoes progressive and not immediate disintegration and exfoliation.
The mechanisms that determine necrosis
resulting from extravasations are different:
– Some drugs bind to nucleic acids in DNA and
are initially absorbed locally causing cell death. After endocytosis, the death of sur­rounding cells occurs through the release of the drug from dead cells. The repetitive nature of this process strongly delays the healing pro­cesses and can lead to progressive and chronic tissue damage, with deep scars.
– Other drugs do not bind to DNA but are
metabolized, limiting the degree of tissue damage, and therefore are easier to pharmaco­logically neutralize.

65.3.3 Epidemiology

The incidence of extravasations in pediatric age ranges from 0.1 to 6.5% of children undergoing chemotherapy, in other estimates 11–28% in chil­dren admitted to a pediatric intensive care setting. A not recent UK-based survey of regional neona­tal intensive care units published in 2004, esti­mated the incidence of extravasation injuries resulting in skin necrosis to be 38 per 1000 babies. Seventy percent of the cases occurred in preterm infants born before 27weeks’ gestation;
420
G. Ciprandi
4% of infants leave the TIN with signicant functional scars or lesions resulting from extrava­sation lesions [20, 21].
65.3.4 Distribution by Body Area
andCare Setting
The incidence of necrotic injuries due to extrava­sation or drug inltration and the deepness of tis­sue damage are related to various factors, including the infused agent, its concentration and volume, the duration of inltration, the timing of diagnosis, the body site, and gestational age of the patient.
In the pediatric age, especially in the neonatal age, the areas chosen for nding venous accesses are the back of the hand, the forearm, the cubital fossa, the back of the foot, and the epicranial area. These areas are represented by a subcutis that allows easy retrieval of the vessels visible in transparency but, at the same time, they are more delicate and fragile. In situations perceived as more difcult, the positioning of the venous line is always ultrasound-guided, thus reducing possi­ble risk for necrosis. No area of the body is exempt from the risk of extravasation. This is especially true for newborns and for those born preterm or low birth weight (LBW, VLBW, ELBW).

65.3.5 Care

65.3.6 Physiology of Extravasation

In the human body, vascular lesions, oxidative stress, and inammation are closely related. Inltration and extravasation are both condi­tions responsible for vascular damage. When a vascular injury occurs, the release of free radi­cals is stimulated and the cells’ ability to pro­duce energy becomes dysfunctional due to damage to the mitochondria. This leads to lim­ited energy production, and the balance between nitric oxide and superoxide is disrupted, increas­ing the damage. There is a continuous cycle of free radical production and endothelial apopto­sis leading to damage to membranes and cell vessels.
Symptoms of this process include redness, swelling, and visible tissue lesions. The interac­tion of the biological response to chemical and non-chemical risk factors, when exposed to the extravasated drug, directly affects the healthy endothelium, leading to vascular lesions, starting from the vessel intima. Inltration or extravasa­tion can be caused by displacement of the intra­venous catheter, puncture of the vein during insertion or handling of patients. The tolerance of the vein to an infusion is inuenced by the osmo­larity and pH of the blistering substance, the duration of exposure, and the irritation of the endothelial cells. An additional factor in causing the vein to rupture and leak is the pressure of the drug being infused.
When the rst signs or symptoms of extravasa­tion or inltration occur, including, for example, redness or edema, the current infusion must be stopped immediately and the team involved. After stopping the infusion, the necessary anti­dote is administered through the same device within 1 h and then the device with the entire infusion line is removed. If the device was removed before administering the antidote, administer the antidote by subcutaneous injec­tions in the area affected by the extravasation. The limb is then placed in unloading for at least 48h to allow normal absorption and drainage of liquids. To facilitate the management of extrava­sation in “rst aid,” the Team has an antidote kit with the various procedures to be performed.
65.3.7 Factors Aecting
thePathophysiology of Extravasation
The volume of the drug infused; since, as is
known, during extravasation there is a loss of
uids in the subcutis which impart pressure to
the venous reticulum and then to the arterial
one, present at the site of the extravasation,
thus reducing the blood supply to others;
therefore, depending on the volume of the
extravasated drug, there will be more or less
severe ischemic damage.
The local toxicity of the drug, due to the chem-
ical nature of the substance itself.